Business
CSL (ASX:CSL) share price wobbles on COVID vaccine news – The Motley Fool Australia
The CSL Limited (ASX: CSL) share price is on watch after the UK found “possible links” between the AstraZeneca vaccine and blood clots.
The CSL Limited (ASX: CSL) share price is a little wobbly this morning after negative vaccine news overnight from the United Kingdom.
The pharmaceutical giant, which produces and supplies the AstraZeneca PLC (LSE: AZ)COVID-19 vaccine in Australia, is trading close to its opening price after news that the UK medical regulator has found a “possible link” between the vaccine and blood clotting in younger adults. The regulator noted that blood clotting was considered a rare side-effect of the vaccine.
…
-
Noosa News22 hours agoDrivers call out bad manners and most hated acts on Queensland roads
-
Business23 hours agoHow to build a $250,000 passive income portfolio starting from zero
-
Noosa News24 hours agoBrisbane Lions looking for rookie Levi Ashcroft to step up against Gold Coast in absence of Lachie Neale
-
Noosa News22 hours agoCoochin Fields developer asked to explain shortfalls in tourist park proposal